Literature DB >> 16547526

Dual, but not selective, COX-1 and COX-2 inhibitors, attenuate acetic acid-evoked bladder irritation in the anaesthetised female cat.

Alexandra Wibberley1, Gerald P McCafferty, Christopher Evans, Richard M Edwards, J Paul Hieble.   

Abstract

Non-selective cyclooxygenase (COX) inhibitors exert effects on lower urinary tract function in several species. The exact contributions of COX-1 and COX-2 isozymes have not been studied much. The present studies investigated the effects of non- and selective COX inhibitors on bladder irritation in the cat.Chloralose-anaesthetised female cats were catheterised through the bladder dome for cystometric evaluation of bladder responses to intravesical infusion of saline or acetic acid. Bladder capacity, voiding efficiency, threshold pressure, and reflex-evoked bladder contraction amplitude and duration were measured. The cat COX selectivity of the doses of inhibitors examined was determined using an in vitro whole-blood assay and analysis of plasma levels. Pretreatment with indomethacin or ketoprofen (non-selective COX inhibitors; 0.3 mg kg(-1) i.v.) inhibited acetic acid-evoked irritation (characterised by a decrease in bladder capacity in vehicle pretreated animals). FR-122047 (selective COX-1 inhibitor), NS-398 and nimesulide (selective COX-2 inhibitors; 1 and 3 mg kg(-1) i.v.) had no effects on bladder irritation. Analysis of plasma levels of the doses examined and determination of COX-1 and COX-2 inhibition in cat whole blood confirmed the reported selectivity of these compounds in this species. The present studies suggest that dual COX inhibition is required to attenuate acetic acid-evoked bladder irritation in the cat.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16547526      PMCID: PMC1617054          DOI: 10.1038/sj.bjp.0706715

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

Review 1.  Choosing the right nonsteroidal anti-inflammatory drug for the right patient: a pharmacokinetic approach.

Authors:  N M Davies; N M Skjodt
Journal:  Clin Pharmacokinet       Date:  2000-05       Impact factor: 6.447

Review 2.  Pharmacodynamics and pharmacokinetics of nonsteroidal anti-inflammatory drugs in species of veterinary interest.

Authors:  P Lees; M F Landoni; J Giraudel; P L Toutain
Journal:  J Vet Pharmacol Ther       Date:  2004-12       Impact factor: 1.786

3.  Bladder Adelta afferent nerve activity in normal cats and cats with feline interstitial cystitis.

Authors:  James R Roppolo; Changfeng Tai; August M Booth; C A Tony Buffington; William C de Groat; Lori A Birder
Journal:  J Urol       Date:  2005-03       Impact factor: 7.450

4.  Pharmacological evaluation of the role of cyclooxygenase isoenzymes on the micturition reflex following experimental cystitis in rats.

Authors:  A Lecci; L A Birder; S Meini; R M Catalioto; M Tramontana; S Giuliani; M Criscuoli; C A Maggi
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

5.  The analgesic effect profile of FR122047, a selective cyclooxygenase-1 inhibitor, in chemical nociceptive models.

Authors:  T Ochi; Y Motoyama; T Goto
Journal:  Eur J Pharmacol       Date:  2000-03-10       Impact factor: 4.432

6.  PGHS-2 inhibitors, NS-398 and DuP-697, attenuate the inhibition of PGHS-1 by aspirin and indomethacin without altering its activity.

Authors:  M Rosenstock; A Danon; G Rimon
Journal:  Biochim Biophys Acta       Date:  1999-08-25

Review 7.  PK-PD integration and PK-PD modelling of nonsteroidal anti-inflammatory drugs: principles and applications in veterinary pharmacology.

Authors:  P Lees; J Giraudel; M F Landoni; P L Toutain
Journal:  J Vet Pharmacol Ther       Date:  2004-12       Impact factor: 1.786

8.  Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis.

Authors:  T D Warner; F Giuliano; I Vojnovic; A Bukasa; J A Mitchell; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

9.  Cyclooxygenase-2 protein and prostaglandin E(2) production are up-regulated in a rat bladder inflammation model.

Authors:  M A Wheeler; J H Yoon; L E Olsson; R M Weiss
Journal:  Eur J Pharmacol       Date:  2001-04-13       Impact factor: 4.432

Review 10.  Nimesulide: some pharmaceutical and pharmacological aspects--an update.

Authors:  A K Singla; M Chawla; A Singh
Journal:  J Pharm Pharmacol       Date:  2000-05       Impact factor: 3.765

View more
  8 in total

1.  Novel 3-Oxazolidinedione-6-aryl-pyridinones as Potent, Selective, and Orally Active EP3 Receptor Antagonists.

Authors:  Jian Jin; Angel Morales-Ramos; Patrick Eidam; John Mecom; Yue Li; Carl Brooks; Mark Hilfiker; David Zhang; Ning Wang; Dongchuan Shi; Pei-San Tseng; Karen Wheless; Brian Budzik; Karen Evans; Jon-Paul Jaworski; Jack Jugus; Lisa Leon; Charlene Wu; Mark Pullen; Bhumika Karamshi; Parvathi Rao; Emma Ward; Nicholas Laping; Christopher Evans; Colin Leach; Dennis Holt; Xin Su; Dwight Morrow; Harvey Fries; Kevin Thorneloe; Richard Edwards
Journal:  ACS Med Chem Lett       Date:  2010-05-14       Impact factor: 4.345

2.  Muscle cyclo-oxygenase-2 pathway contributes to the exaggerated muscle mechanoreflex in rats with congestive heart failure.

Authors:  Ariel Morales; Wei Gao; Jian Lu; Jihong Xing; Jianhua Li
Journal:  Exp Physiol       Date:  2012-04-20       Impact factor: 2.969

3.  Impact of hematopoietic cyclooxygenase-1 deficiency on obesity-linked adipose tissue inflammation and metabolic disorders in mice.

Authors:  Viswanathan Saraswathi; Christopher J Ramnanan; Anson W Wilks; Cyrus V Desouza; Amy A Eller; Ganesan Murali; Ramesh Ramalingam; Ginger L Milne; Katie C Coate; Dale S Edgerton
Journal:  Metabolism       Date:  2013-08-27       Impact factor: 8.694

4.  Dual modulation of urinary bladder activity and urine flow by prostanoid EP3 receptors in the conscious rat.

Authors:  M J Jugus; J P Jaworski; P B Patra; J Jin; D M Morrow; N J Laping; R M Edwards; K S Thorneloe
Journal:  Br J Pharmacol       Date:  2009-05-22       Impact factor: 8.739

5.  Enhancement of antinociception by coadministration of minocycline and a non-steroidal anti-inflammatory drug indomethacin in naïve mice and murine models of LPS-induced thermal hyperalgesia and monoarthritis.

Authors:  Ala'a Ahmed Abu-Ghefreh; Willias Masocha
Journal:  BMC Musculoskelet Disord       Date:  2010-12-01       Impact factor: 2.362

6.  Stability of the acetic acid-induced bladder irritation model in alpha chloralose-anesthetized female cats.

Authors:  F Aura Kullmann; Grace I Wells; Christopher L Langdale; Jihong Zheng; Karl B Thor
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

7.  Impaired Expression of Prostaglandin E2 (PGE2) Synthesis and Degradation Enzymes during Differentiation of Immortalized Urothelial Cells from Patients with Interstitial Cystitis/Painful Bladder Syndrome.

Authors:  John O Marentette; Robert E Hurst; Jane McHowat
Journal:  PLoS One       Date:  2015-06-09       Impact factor: 3.240

8.  Potential for control of detrusor smooth muscle spontaneous rhythmic contraction by cyclooxygenase products released by interstitial cells of Cajal.

Authors:  Clinton Collins; Adam P Klausner; Benjamin Herrick; Harry P Koo; Amy S Miner; Scott C Henderson; Paul H Ratz
Journal:  J Cell Mol Med       Date:  2009-02-20       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.